Nas, O. F.İnecikli, M. F.Kaçar, E.Büyükkaya, R.Özkaya, G.Aydın, O.Erdoğan, C.Hakyemez, B.2024-08-082024-08-082015-11-012211-5684https://doi.org/10.1016/j.diii.2015.05.001https://www.sciencedirect.com/science/article/pii/S2211568415001916https://hdl.handle.net/11452/43816Purpose and objectives: To assess the effectiveness of percutaneous vertebroplasty (PV) in patients with vertebral collapse due to metastases.Materials and methods: PV procedures performed on 95 vertebras in 52 patients with primary malignancy were retrospectively evaluated. Vertebral metastases, primary malignancies of the patients, pain before and after PV on a visual analogue scale (VAS), amount of polymethylmethacrylate (PMMA) cement applied to the vertebral body during PV, PMMA cement leakage and vertebral approaches were evaluated.Results: VAS scores of 43 patients (in total 79 vertebras) were evaluated. Median VAS scores of patients declined from 8 (4-10) before PV to 3 (0-7) within one day after the procedure, to 2 (0-9) one week after the procedure and eventually to 2 (0-9) 3 months after the procedure (p < 0.001). PMMA amount applied to the vertebral body during PV varied between 1.5-9 mL (average +/- SD 4.91 +/- 1.61). There was no significant statistical correlation between PMMA amounts and VAS scores within one day after, 1 week after and 3 months after the PV procedure (p > 0.05).Conclusion: PV is a simple, effective, reliable, easy to perform and minimally invasive procedure in patients with painful vertebral metastases.eninfo:eu-repo/semantics/closedAccessSpinal metastasesInterventional radiologyNeurological surgeonsAmerican associationPosition statementNeuroradiologyAugmentationEfficacySocietyCementPercutaneous vertebroplasty (PV)Vertebral metastasesVisual analogue scale (VAS)Polymethylmethacry-late (pmma)Radiology, nuclear medicine & medical imagingArticle00036327890000911611168961110.1016/j.diii.2015.05.001